Budapest, Hungary

Krisztina Vukics


 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Krisztina Vukics

Introduction

Krisztina Vukics is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor functions. With a total of 3 patents to her name, her work has implications for various medical treatments.

Latest Patents

One of her latest patents is titled "Triazolobenzazepines as vasopressin V1a receptor antagonists." This invention relates to a series of derivatives that act as V1a receptor modulators, particularly antagonists. The patent outlines the preparation process for these compounds and their potential use in treating conditions associated with V1a receptor function. Another significant patent is for the "Process for the production of ezetimibe and intermediates used in this process." This patent details a method for producing ezetimibe, a compound used to lower cholesterol levels, along with the necessary intermediates involved in the production process.

Career Highlights

Krisztina has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Nyrt. and Richter Gedeon. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in drug development.

Collaborations

Throughout her career, Krisztina has collaborated with esteemed colleagues such as Tamas Fodor and Janos Fischer. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Krisztina Vukics is a pioneering inventor whose work in pharmaceuticals has led to valuable patents and advancements in medical treatments. Her contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…